<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   3258
  </number>
  <updateDate>
   2023-01-11T13:49:45Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:49:45Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-05-14
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 84 (Friday, May 14, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. SEWELL:H.R. 3258.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the U.S. Constitution.[Page H2357]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-05-17T16:46:29Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-05-14T13:00:26Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-05-17
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-05-14
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-05-14
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-05-14
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     S001185
    </bioguideId>
    <fullName>
     Rep. Sewell, Terri A. [D-AL-7]
    </fullName>
    <firstName>
     Terri
    </firstName>
    <lastName>
     Sewell
    </lastName>
    <party>
     D
    </party>
    <state>
     AL
    </state>
    <middleName>
     A.
    </middleName>
    <district>
     7
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001257
    </bioguideId>
    <fullName>
     Rep. Bilirakis, Gus M. [R-FL-12]
    </fullName>
    <firstName>
     Gus
    </firstName>
    <lastName>
     Bilirakis
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-05-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     F000466
    </bioguideId>
    <fullName>
     Rep. Fitzpatrick, Brian K. [R-PA-1]
    </fullName>
    <firstName>
     Brian
    </firstName>
    <lastName>
     Fitzpatrick
    </lastName>
    <party>
     R
    </party>
    <state>
     PA
    </state>
    <middleName>
     K.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-06-14
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     R000609
    </bioguideId>
    <fullName>
     Rep. Rutherford, John H. [R-FL-4]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Rutherford
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <middleName>
     H.
    </middleName>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-07-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000302
    </bioguideId>
    <fullName>
     Rep. Joyce, John [R-PA-13]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Joyce
    </lastName>
    <party>
     R
    </party>
    <state>
     PA
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2021-07-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001108
    </bioguideId>
    <fullName>
     Rep. Comer, James [R-KY-1]
    </fullName>
    <firstName>
     James
    </firstName>
    <lastName>
     Comer
    </lastName>
    <party>
     R
    </party>
    <state>
     KY
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-09-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     L000491
    </bioguideId>
    <fullName>
     Rep. Lucas, Frank D. [R-OK-3]
    </fullName>
    <firstName>
     FRANK
    </firstName>
    <lastName>
     LUCAS
    </lastName>
    <party>
     R
    </party>
    <state>
     OK
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-11-17
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000826
    </bioguideId>
    <fullName>
     Rep. Wild, Susan [D-PA-7]
    </fullName>
    <firstName>
     Susan
    </firstName>
    <lastName>
     Wild
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2022-03-17
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000617
    </bioguideId>
    <fullName>
     Rep. DelBene, Suzan K. [D-WA-1]
    </fullName>
    <firstName>
     Suzan
    </firstName>
    <lastName>
     DelBene
    </lastName>
    <party>
     D
    </party>
    <state>
     WA
    </state>
    <middleName>
     K.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-03-29
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000197
    </bioguideId>
    <fullName>
     Rep. DeGette, Diana [D-CO-1]
    </fullName>
    <firstName>
     DIANA
    </firstName>
    <lastName>
     DEGETTE
    </lastName>
    <party>
     D
    </party>
    <state>
     CO
    </state>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-03-29
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000389
    </bioguideId>
    <fullName>
     Rep. Khanna, Ro [D-CA-17]
    </fullName>
    <firstName>
     Ro
    </firstName>
    <lastName>
     Khanna
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     17
    </district>
    <sponsorshipDate>
     2022-05-17
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     Z000017
    </bioguideId>
    <fullName>
     Rep. Zeldin, Lee M. [R-NY-1]
    </fullName>
    <firstName>
     Lee
    </firstName>
    <lastName>
     Zeldin
    </lastName>
    <party>
     R
    </party>
    <state>
     NY
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-05-27
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001218
    </bioguideId>
    <fullName>
     Rep. Stansbury, Melanie Ann [D-NM-1]
    </fullName>
    <firstName>
     Melanie
    </firstName>
    <lastName>
     Stansbury
    </lastName>
    <party>
     D
    </party>
    <state>
     NM
    </state>
    <middleName>
     Ann
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2022-05-27
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001291
    </bioguideId>
    <fullName>
     Rep. Babin, Brian [R-TX-36]
    </fullName>
    <firstName>
     Brian
    </firstName>
    <lastName>
     Babin
    </lastName>
    <party>
     R
    </party>
    <state>
     TX
    </state>
    <district>
     36
    </district>
    <sponsorshipDate>
     2022-06-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001300
    </bioguideId>
    <fullName>
     Rep. Barragan, Nanette Diaz [D-CA-44]
    </fullName>
    <firstName>
     Nanette
    </firstName>
    <lastName>
     Barragan
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <middleName>
     Diaz
    </middleName>
    <district>
     44
    </district>
    <sponsorshipDate>
     2022-08-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001039
    </bioguideId>
    <fullName>
     Rep. Cammack, Kat [R-FL-3]
    </fullName>
    <firstName>
     Kat
    </firstName>
    <lastName>
     Cammack
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2022-09-19
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects/>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-05-14
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2022-02-03T00:30:14Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames.&lt;br /&gt; &lt;br /&gt; Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization.&lt;br /&gt; &lt;br /&gt; Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing.&lt;br /&gt; &lt;br /&gt; The Government Accountability Office must evaluate and report on the implementation of these requirements.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   TACT Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     TACT Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend title XXVII of the Public Health Service Act to improve patient access to anti-cancer oral medications, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     TACT Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Timely Access to Cancer Treatment Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-05-14T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr3258ih/xml/BILLS-117hr3258ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-05-17
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-05-17
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-05-14
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-05-14
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-05-14
9
Library of Congress
Introduced in House
IntroReferral
2021-05-14T13:00:26Z
Referred to
House
Energy and Commerce Committee
2021-05-17T16:46:29Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
B001257
12
Gus
Rep. Bilirakis, Gus M. [R-FL-12]
Bilirakis
M.
R
2021-05-14
FL
F000466
1
Brian
Rep. Fitzpatrick, Brian K. [R-PA-1]
Fitzpatrick
K.
R
2021-06-14
PA
R000609
4
John
Rep. Rutherford, John H. [R-FL-4]
Rutherford
H.
R
2021-07-16
FL
J000302
13
John
Rep. Joyce, John [R-PA-13]
Joyce
R
2021-07-16
PA
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2021-09-21
KY
L000491
3
FRANK
Rep. Lucas, Frank D. [R-OK-3]
LUCAS
D.
R
2021-11-17
OK
W000826
7
Susan
Rep. Wild, Susan [D-PA-7]
Wild
D
2022-03-17
PA
D000617
1
Suzan
Rep. DelBene, Suzan K. [D-WA-1]
DelBene
K.
D
2022-03-29
WA
D000197
1
DIANA
Rep. DeGette, Diana [D-CO-1]
DEGETTE
D
2022-03-29
CO
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2022-05-17
CA
Z000017
1
Lee
Rep. Zeldin, Lee M. [R-NY-1]
Zeldin
M.
R
2022-05-27
NY
S001218
1
Melanie
Rep. Stansbury, Melanie Ann [D-NM-1]
Stansbury
Ann
D
2022-05-27
NM
B001291
36
Brian
Rep. Babin, Brian [R-TX-36]
Babin
R
2022-06-21
TX
B001300
44
Nanette
Rep. Barragan, Nanette Diaz [D-CA-44]
Barragan
Diaz
D
2022-08-02
CA
C001039
3
Kat
Rep. Cammack, Kat [R-FL-3]
Cammack
R
2022-09-19
FL
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-05-14
2021-05-17
Referred to the Subcommittee on Health.
House
Health
S001185
7
Terri
Rep. Sewell, Terri A. [D-AL-7]
N
Sewell
A.
D
AL
2021-05-14
Introduced in House
 <p><strong>Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021</strong></p> <p>This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames.<br /> <br /> Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization.<br /> <br /> Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing.<br /> <br /> The Government Accountability Office must evaluate and report on the implementation of these requirements.</p>
2022-02-03T00:30:14Z
00
2021-05-14T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr3258ih/xml/BILLS-117hr3258ih.xml
TACT Act of 2021
TACT Act of 2021
Display Title
IH
Introduced in House
To amend title XXVII of the Public Health Service Act to improve patient access to anti-cancer oral medications, and for other purposes.
Official Title as Introduced
IH
Introduced in House
TACT Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Timely Access to Cancer Treatment Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:49:45Z
2023-01-11T13:49:45Z
3.0.0
2021-05-17
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-05-14
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-05-14
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-05-14
9
Library of Congress
Introduced in House
IntroReferral
S001185
7
Terri
Rep. Sewell, Terri A. [D-AL-7]
N
Sewell
A.
D
AL
B001257
12
Gus
Rep. Bilirakis, Gus M. [R-FL-12]
Bilirakis
M.
R
2021-05-14
FL
F000466
1
Brian
Rep. Fitzpatrick, Brian K. [R-PA-1]
Fitzpatrick
K.
R
2021-06-14
PA
R000609
4
John
Rep. Rutherford, John H. [R-FL-4]
Rutherford
H.
R
2021-07-16
FL
J000302
13
John
Rep. Joyce, John [R-PA-13]
Joyce
R
2021-07-16
PA
C001108
1
James
Rep. Comer, James [R-KY-1]
Comer
R
2021-09-21
KY
L000491
3
FRANK
Rep. Lucas, Frank D. [R-OK-3]
LUCAS
D.
R
2021-11-17
OK
W000826
7
Susan
Rep. Wild, Susan [D-PA-7]
Wild
D
2022-03-17
PA
D000617
1
Suzan
Rep. DelBene, Suzan K. [D-WA-1]
DelBene
K.
D
2022-03-29
WA
D000197
1
DIANA
Rep. DeGette, Diana [D-CO-1]
DEGETTE
D
2022-03-29
CO
K000389
17
Ro
Rep. Khanna, Ro [D-CA-17]
Khanna
D
2022-05-17
CA
Z000017
1
Lee
Rep. Zeldin, Lee M. [R-NY-1]
Zeldin
M.
R
2022-05-27
NY
S001218
1
Melanie
Rep. Stansbury, Melanie Ann [D-NM-1]
Stansbury
Ann
D
2022-05-27
NM
B001291
36
Brian
Rep. Babin, Brian [R-TX-36]
Babin
R
2022-06-21
TX
B001300
44
Nanette
Rep. Barragan, Nanette Diaz [D-CA-44]
Barragan
Diaz
D
2022-08-02
CA
C001039
3
Kat
Rep. Cammack, Kat [R-FL-3]
Cammack
R
2022-09-19
FL
2021-05-14
Introduced in House
 <p><strong>Timely Access to Cancer Treatment Act of 2021 or the TACT Act of 2021</strong></p> <p>This bill requires insurance plans to authorize, and pharmacies contracted with the plans to dispense, anti-cancer oral medications within certain time frames.<br /> <br /> Specifically, within 24 hours after receiving a prescription, a pharmacy must inform the health care provider and plan enrollee whether it will dispense the medication. If the pharmacy will dispense the medication, it must do so within 72 hours after receiving the prescription. If the pharmacy is unable to dispense the medication, it must notify in writing the prescribing health care provider, the insurance plan, and the plan enrollee. A plan that requires prior authorization for anti-cancer oral medication must make that determination within 72 hours after receiving the request for authorization.<br /> <br /> Further, if a pharmacy provides notification that it is unable to dispense the medication, the health insurance plan must allow the enrollee to select a different pharmacy to dispense the medication, even if that pharmacy does not have a contract with the plan. In such a case, the plan may not require additional prior authorization or cost sharing.<br /> <br /> The Government Accountability Office must evaluate and report on the implementation of these requirements.</p>
2022-02-03T00:30:14Z
00
TACT Act of 2021
TACT Act of 2021
Display Title
IH
Introduced in House
To amend title XXVII of the Public Health Service Act to improve patient access to anti-cancer oral medications, and for other purposes.
Official Title as Introduced
IH
Introduced in House
TACT Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Timely Access to Cancer Treatment Act of 2021
Short Title(s) as Introduced
2021-05-17
Referred to the Subcommittee on Health.